A H Calvert
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
- Cancer Research top 5%
Papers in
- Oncology 52
- Colorectal Cancer Treatments and Studies 21
- Cancer Treatment and Pharmacology 14
-
- Ovarian cancer diagnosis and treatment 9
- Co-authors
- Ann L. JackmanDavid R. NewellA.L. JackmanNicola J. CurtinRoger J. GriffinTerence R. JonesK.R. HarrapE. Wiltshaw
- Journals
- British Journal of Cancer (16 papers)Journal of Clinical Oncology (9 papers)European Journal of Cancer (7 papers)Clinical Cancer Research (4 papers)Journal of Medicinal Chemistry (4 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
A H Calvert
88 papers receiving 3.6k citations
Peers
Comparison fields: 5 of 105
- Oncology 2.0k
- Cancer Research 443
- Molecular Biology 1.9k
- Pulmonary and Respiratory Medicine 719
- Rheumatology 329
Countries citing papers authored by A H Calvert
This map shows the geographic impact of A H Calvert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A H Calvert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A H Calvert more than expected).
Fields of papers citing papers by A H Calvert
This network shows the impact of papers produced by A H Calvert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A H Calvert. The network helps show where A H Calvert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A H Calvert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 25 | |
| 2 | 2008 | 22 | |
| 3 | A phase 1b study to assess the safety of lexatumumab, a human monoclonal antibody that activates TRAIL-R2, in combination with gemcitabine, pemetrexed, doxorubicin or FOLFIRI. | 2007 | 33 |
| 4 | Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide | 2005 | 6 |
| 5 | 2005 | 79 | |
| 6 | Design and evaluation of novel potent inhibitors of poly (ADP-ribose) polymerase | 2000 | 1 |
| 7 | Paclitaxel and carboplatin dose-intensity and duration of infusion in the treatment of ovarian cancer | 2000 | 1 |
| 8 | Plasma 2 '-deoxyuridine (dUrd) as a surrogate marker of thymidylate synthase (TS) inhibition in patients in phase I clinical trials of the TS inhibitor ZD9331 | 1998 | 1 |
| 9 | 1997 | 3 | |
| 10 | 1996 | 23 | |
| 11 | 1995 | 33 | |
| 12 | 1995 | 45 | |
| 13 | 1995 | 129 | |
| 14 | 1993 | 30 | |
| 15 | 1992 | 47 | |
| 16 | 1991 | 25 | |
| 17 | 1991 | 6 | |
| 18 | DIPYRIDAMOLE INDUCED-INHIBITION OF THYMIDINE INCORPORATION INVIVO AND POTENTIATION OF CB3717 CYTO-TOXICITY INVITRO | 1985 | 2 |
| 19 | BIOCHEMICAL DISTURBANCES OBSERVED INVITRO AND INVIVO FOLLOWING INHIBITION OF THYMIDYLATE SYNTHETASE BY C-3717 | 1982 | 1 |
| 20 | 2-AMINO-4-HYDROXY QUINAZOLINE ANALOGS OF FOLIC-ACID AS THYMIDYLATE SYNTHETASE INHIBITORS | 1979 | 1 |
About A H Calvert
A H Calvert is a scholar working on Oncology, Reproductive Medicine, Molecular Biology, Organic Chemistry and Genetics, having authored 89 papers that have together received 3.7k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (30 papers), Colorectal Cancer Treatments and Studies (21 papers), Cancer therapeutics and mechanisms (14 papers), Cancer Treatment and Pharmacology (14 papers), Quinazolinone synthesis and applications (13 papers), Lung Cancer Treatments and Mutations (9 papers), Ovarian cancer diagnosis and treatment (9 papers) and Folate and B Vitamins Research (7 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (443 citations), Molecular Biology (1.9k citations), Pulmonary and Respiratory Medicine (719 citations) and Rheumatology (329 citations). A H Calvert has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Ann L. Jackman, David R. Newell, A.L. Jackman, Nicola J. Curtin, Roger J. Griffin, Terence R. Jones, K.R. Harrap, E. Wiltshaw, Rosemary Kimbell and William Gibson. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, European Journal of Cancer, Clinical Cancer Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.